- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
University of Alabama at Birmingham
Headquarters: Birmingham, AL, United States of America
Website: http://www.uab.edu/home
Year Founded: 1936
Status: Non-biopharma
Biopharma related deals can be found by searching the organization's name in the Deals Module.
BioCentury | Aug 4, 2023
Management Tracks
Karuna names new CFO and HR head
Plus: Freeman joins Zentalis as chief strategy officer, and updates from Complement,
BioCentury | Apr 1, 2022
Distillery Therapeutics
iPSC-derived cell therapy for diabetic microvascular complications
BioCentury | Jan 27, 2022
Management Tracks
Adaptimmune hires Piccina as CCO as it readies for first BLA
Plus Rowe new CSO at Cystic Fibrosis Foundation and updates from Immunovant, Senda, F2G and more
BioCentury | Sep 12, 2020
Politics, Policy & Law
NIH taking action on racial disparities in Alzheimer’s research
The National Institute of Aging (NIA) aims to address racial disparities in Alzheimer’s disease research by creating four new centers dedicated to investigating the disease in underrepresented
BioCentury | Jul 15, 2020
Product Development
University of Queensland COVID-19 vaccine becomes seventh with CEPI funding to enter the clinic
Plus Altimmune vaccine heads towards the clinic, and Fast Track for Pfizer, BioNTech candidates
BioCentury | Jun 26, 2020
Distillery Therapeutics
Promoting Golgi fragmentation to treat pancreatic cancer
BioCentury | Mar 31, 2020
Product Development
COVID roundup: Vaccine R&D from Murdoch Children’s, Cobra-Karolinska, Altimmune-Alabama
BioCentury is providing this story for free given the urgent need for information about the COVID-19 crisis. For more analysis, sign up for our daily email.
BioCentury | Nov 1, 2019
Product Development
Vertex’s triple therapy will reshape the landscape of cystic fibrosis trials
Trikafta approval extends Vertex’s dominance, pushes competitors to rare mutations and new trial designs
Items per page:
1 - 10 of 104